Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001539497-25-003250·Kaos Capital Ltd
Schedule 13D ownership disclosure
PSYENCE BIOMEDICAL LTD
Common Stock, without par value · CUSIP: 74449F308
Event date: 2025-11-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- KAOS Capital Ltd.Reported CIK 0002100448
Shares: 313,876.00 · Class: 16.77%
- Adam ArvivReported CIK 0002100451
Shares: 313,876.00 · Class: 16.77%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001539497-25-003250
- Form type
- SCHEDULE 13D
- Filer
- Kaos Capital Ltd
- CIK
- CIK 2100448
- Filed
- Dec 10, 2025
- Reporting period
- Nov 25, 2025
- Description
- Schedule 13D beneficial ownership